Sunday, September 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Teradata Shares: A Market Divided on Data Analytics Future

Dieter Jaworski by Dieter Jaworski
September 21, 2025
in Analysis, Tech & Software, Trading & Momentum
0
Teradata Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Teradata Corporation finds itself at the center of a complex investment narrative. Despite significant position increases from several major funds, the stock price remains under pressure, reflecting a deeply divided outlook among market professionals. The relatively modest price movements in recent trading sessions mask an intense debate regarding the data analytics specialist’s strategic direction.

Wall Street’s Cautious Stance

The analyst community reflects this uncertainty. The current consensus recommendation stands at “Hold,” but this masks a wide dispersion of views. Detailed ratings show three analysts advocating a “Buy,” five recommending “Hold,” and two issuing a “Sell” recommendation. While the average price target of $26.86 suggests a potential upside exceeding 21%, this outlook was recently tempered by Zacks Research downgrading the stock to a “Strong Sell” rating.

Institutional Investors Send Mixed Messages

The trading activity of large investors further illustrates the conflicting sentiment. Institutional players hold over 90% of Teradata shares, and their recent transactions paint a contradictory picture. While certain funds substantially reduced their holdings, other major institutions moved in the opposite direction. Vanguard Group increased its stake by 5.6%, and Lynrock Lake amplified its position by a notable 37.6%. In a particularly striking move, LSV Asset Management nearly doubled its investment in the company. These opposing actions highlight a fundamental lack of consensus among sophisticated market participants.

Should investors sell immediately? Or is it worth buying Teradata?

Quarterly Results: A Dual Narrative

The company’s latest quarterly report, released in August, presented a mixed bag of results. Teradata managed to surpass expectations for both earnings per share (EPS) and revenue. However, this operational strength was counterbalanced by a concerning 6.4% year-over-year decline in total revenue. This combination of beating short-term estimates while facing a longer-term growth contraction explains the market’s hesitant and measured response.

The pivotal question for investors is whether Teradata can successfully execute its cloud and data analytics strategy to not only exceed quarterly expectations but also reestablish a trajectory of sustainable growth. The upcoming quarterly earnings report is anticipated to provide critical insight into the company’s direction.

Ad

Teradata Stock: Buy or Sell?! New Teradata Analysis from September 21 delivers the answer:

The latest Teradata figures speak for themselves: Urgent action needed for Teradata investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 21.

Teradata: Buy or sell? Read more here...

Tags: Teradata
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Pharma & Biotech

Viking Therapeutics Stock Stages Impressive Recovery

September 21, 2025
Fiserv Stock
Earnings

Fiserv Faces Investor Backlash Amid Clover Platform Concerns

September 21, 2025
OppFi Stock
Earnings

OppFi Stock: A Study in Contrasting Market Signals

September 21, 2025
Next Post
DXP Stock

DXP Enterprises Faces Headwinds as Insider Selling and Analyst Caution Emerge

Walgreens Stock

Walgreens Concludes Public Market Era with Landmark Private Equity Acquisition

Herman Miller Stock

MillerKnoll Faces Pivotal Week with Q1 Earnings Release

Recommended

OHI stock news

Strategic Acquisition and Dividend Payment by Flputnam Investment Management Co.: A Showcase of Expertise in Small-Cap Growth Investments

2 years ago
Real Estate Investment Stock Market Today

Analyst Reaffirms Market Outperform Rating for Lennar with 170 Price Target

2 years ago
Farmers National Banc /OH Stock

A Regional Banking Powerhouse: Farmers National Banc’s Unwavering Dividend Commitment

1 week ago
EverCommerce Stock

Insider Sales at EverCommerce Follow Strong Quarterly Performance

4 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ralph Lauren’s Strategic Vision Fails to Impress Market

OppFi Stock: A Study in Contrasting Market Signals

Is SM Energy Stock a Value Opportunity or a Value Trap?

Debt Reduction Strategy Yields Mixed Results for Diversified Healthcare Trust

Lufax Shares Gain Momentum Ahead of Quarterly Earnings Release

MillerKnoll Faces Pivotal Week with Q1 Earnings Release

Trending

Viking Therapeutics Stock
Pharma & Biotech

Viking Therapeutics Stock Stages Impressive Recovery

by Felix Baarz
September 21, 2025
0

Viking Therapeutics shares registered substantial double-digit gains late last week, propelled by favorable sector developments and sustained...

Fiserv Stock

Fiserv Faces Investor Backlash Amid Clover Platform Concerns

September 21, 2025
Conagra Brands Stock

Key Financial Executive Departs Conagra Brands Ahead of Earnings

September 21, 2025
Ralph Lauren Stock

Ralph Lauren’s Strategic Vision Fails to Impress Market

September 21, 2025
OppFi Stock

OppFi Stock: A Study in Contrasting Market Signals

September 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics Stock Stages Impressive Recovery
  • Fiserv Faces Investor Backlash Amid Clover Platform Concerns
  • Key Financial Executive Departs Conagra Brands Ahead of Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com